18:25 , Apr 10, 2017 |  BC Extra  |  Financial News

Biohaven planning $100M IPO

Biohaven Pharmaceutical Holding Co. Ltd. (New Haven, Conn.) filed to raise up to $100 million in an IPO on the New York Stock Exchange underwritten by Morgan Stanley, Piper Jaffray, Barclays, William Blair and Needham....
02:08 , Nov 5, 2016 |  BioCentury  |  Finance

Craving Biohaven

Biohaven Pharmaceutical Holding Co. Ltd. raised a tranched $80 million private round on its management team’s track record of bringing neurology compounds through the clinic, and the range of both Orphan and common indications the...
07:00 , Oct 5, 2015 |  BC Week In Review  |  Company News

ALS Biopharma, Biohaven deal

Biohaven purchased from ALS Biopharma worldwide rights to IP covering more than 300 prodrugs. The companies said most of the prodrugs are NMEs that modulate glutamate. Biohaven plans to focus on developing the drugs for...